Top Markets
#1 Black Phoenix Black Phoenix +830.36%
#2 Not in Employment, Education, or Training Not in Employment, Education, or Training +31.42%
#3 Beam Beam +27.08%
#4 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +26.70%
#5 SAFEcoin SAFEcoin +20.82%
#6 Magma Finance Magma Finance +20.71%
#7 pipedog pipedog +20.41%
#8 Bless Bless +16.95%
#9 THORChain THORChain +16.41%
#10 PondCoin PondCoin +16.11%
Coin of the day
Black Phoenix Black Phoenix
설정
언어
한국어
통화
USD
테마
Nanobiotix S.A. Nanobiotix S.A.

Nanobiotix S.A.

NANO
주식 순위 #5977
Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on... Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is based in Paris, France.
주가
$45.79
시가총액
$2.33B
변동 (1일)
11.43%
변동 (1년)
408.10%
국가
FR
거래 Nanobiotix S.A. (NANO)

카테고리

Healthcare
Nanobiotix S.A. (NANO)의 EPS
2026 기준 EPS TTM: 0
Nanobiotix S.A.의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 0입니다. 2026년 말에는 회사의 EPS가 0였으며, 이는 2026년의 EPS 0와 동일입니다.
Nanobiotix S.A.의 EPS 기록 (2026 ~ 2026)
매년 말의 EPS
연도 EPS 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 EPS
회사 EPS EPS 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH